CMN Weekly (24 November 2023) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Nov. 24, 2023
News

#CRISPRMED24

Top picks

Research

Industry

  • Want to know the current standings in the CRISPR patent battle? German IP lawyer and neurobiologist Ulrich Storz gives an overview of the status quo ten years after the seminal patents were filed. He concludes that the licensing situation in CRISPR-Cas9 remains complicated, though the last years have at least unmasked strengths and weaknesses of the seminal patent portfolios owned by the major players. Moreover, it has exposed fundamental differences between the European and American patent systems.

Detection

Reviews

News from CRISPR Medicine News

  • This Monday, we brought an interview with AAV trailblazer Nicole Paulk, formerly of UCSF, who speaks about the latest developments in AAV-based gene therapies and her new company, Siren Biotechnology.
  • On Wednesday, we looked at recent clinical updates from the gene-editing field. These updates include clinical data from ongoing clinical trials for acute myeloid leukaemia and transthyretin amyloidosis and IND clearance for Caribou Biosciences' acute myeloid leukaemia candidate, CB-012.

Huh, heh, wow

To get more of the CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

News: CMN Weekly (24 November 2023) - Your Weekly CRISPR Medicine News
News: CMN Weekly (24 November 2023) - Your Weekly CRISPR Medicine News
CLINICAL TRIALS
Renal Cell Carcinoma, RCC, (NCT06245915)
Sponsors:
Arsenal Biosciences, Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Solid Tumors, (NCT06237881)
Sponsors:
M.D. Anderson Cancer Center
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Breast Cancer, BC, (NCT05812326)
Sponsors:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine